NasdaqGS - Nasdaq Real Time Price USD

Pactiv Evergreen Inc. (PTVE)

Compare
12.34 +0.99 (+8.72%)
As of 10:20 AM EST. Market Open.

Research Analysis

Earnings Per Share

Consensus EPS
?

Revenue vs. Earnings

Revenue 1.34B
Earnings 19M
Q3'23
Q4'23
Q1'24
Q2'24
0
500M
1B
?

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
?

Analyst Price Targets

12.00
14.00 Average
12.34 Current
16.00 High

Earnings Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 6656
Avg. Estimate 0.360.330.991.27
Low Estimate 0.270.190.81.07
High Estimate 0.440.41.151.5
Year Ago EPS 0.320.330.960.99

Revenue Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 6666
Avg. Estimate 1.37B1.26B5.2B5.24B
Low Estimate 1.34B1.17B5.06B4.84B
High Estimate 1.42B1.33B5.34B5.63B
Year Ago Sales 1.38B1.27B5.51B5.2B
Sales Growth (year/est) -0.40%-0.70%-5.60%0.80%

Earnings History

CURRENCY IN USD 9/30/2023 12/31/2023 3/31/2024 6/30/2024
EPS Est. 0.20.210.080.25
EPS Actual 0.320.330.140.17
Difference 0.120.120.06-0.08
Surprise % 60.00%57.10%75.00%-32.00%

EPS Trend

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Current Estimate 0.360.330.991.27
7 Days Ago 0.360.330.991.27
30 Days Ago 0.370.351.021.3
60 Days Ago 0.370.351.021.3
90 Days Ago 0.360.351.011.29

EPS Revisions

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days 1----1
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD PTVEIndustrySectorS&P 500
Current Qtr. 12.50%----5.50%
Next Qtr. 0.00%----11.40%
Current Year 3.10%----2.10%
Next Year 28.30%----12.30%
Next 5 Years (per annum) -17.40%----11.11%
Past 5 Years (per annum) -4.80%------

Upgrades & Downgrades

Maintains UBS: Buy to Buy 8/8/2024
Maintains RBC Capital: Outperform to Outperform 8/7/2024
Maintains Baird: Neutral to Neutral 8/2/2024
Maintains UBS: Buy to Buy 7/17/2024
Maintains Citigroup: Buy to Buy 7/8/2024
Maintains Citigroup: Buy to Buy 4/4/2024

Related Tickers